The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian, endometrial, and cervical cancers.

23-year-old ovarian cancer survivor and 2025 Witchery White Shirt Ambassador Jemima Leydon shares her story with this lethal ...

Dr Emma Bolderson, from QUT's School of Biomedical Sciences, has received a $460,552 grant from the Ovarian Cancer Research ...

Ovarian cancer—known as a silent killer due to its inability to showcase most of its symptoms—kills many women every year across the world. According to studies, over a third of women are not familiar ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Medscape Medical News, November 26, 2007 Hay Fever, Asthma Linked to Lower Prevalence of Ovarian and Cervical Cancer In an observational study of more than 1 million women, those with hay fever ...

In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

India faces a cancer crisis with 3 in 5 patients dying post-diagnosis Women are at higher risk due to late detection limited healthcare access and social barriers ...

On Wednesday, March 12, Derby Crown Court in the U.K. heard that Laura McPherson, 35, had lied to her partner, Jon Leonard, about having breast, bowel, colon, ovarian and cervical cancer ...